Did anyone else watch 9 News tonight (6PM AEST) where Dr James Chong from the Westmead Millennium Institute for Medical Research discussed the huge potential of the stem cell trial he is leading?
I could be wrong, but it sounded very much like our Cymerus technology!
For those that don't know, Cynata announced a collaboration with Dr Chong back in July 2015 to test the potential therapeutic efficacy of its Cymerus™ mesenchymal stem cells (MSCs) in animal models of myocardial infarction (heart attack) and associated heart rhythm abnormalities.
GLTA
CYP Price at posting:
33.0¢ Sentiment: Buy Disclosure: Held
